| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JAAD.2010.11.046 |
| P698 | PubMed publication ID | 21742411 |
| P2093 | author name string | Michael David | |
| Jonathan Shapiro | |||
| Roy Tal | |||
| Dahlia Weitzman | |||
| Arnon David Cohen | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 252-258 | |
| P577 | publication date | 2011-07-13 | |
| P1433 | published in | Journal of the American Academy of Dermatology | Q15757046 |
| P1476 | title | Psoriasis and cardiovascular risk factors: a case-control study on inpatients comparing psoriasis to dermatitis. | |
| P478 | volume | 66 |
| Q89970104 | A systematic review and meta-analysis of the association between psoriasis and hypertension with adjustment for covariates |
| Q34812877 | Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review |
| Q38429390 | Co-morbidities in psoriasis: a hospital-based case-control study |
| Q38402558 | Immune reactivity in psoriatic munro-saboureau microabscesses, stratum corneum and blood vessels. |
| Q34409690 | Metabolic syndrome and its components in patients with psoriasis |
| Q39248840 | Metabolic syndrome in Moroccan patients with psoriasis |
| Q33647531 | Metabolic syndrome in patients with psoriasis: A comparative study |
| Q37420435 | Primary care-based screening for cardiovascular risk factors in patients with psoriasis. |
| Q38151781 | Psoriasis and smoking: a systematic review and meta-analysis |
| Q43693973 | Psoriasis is not associated with atherosclerosis and incident cardiovascular events: the Rotterdam Study |
| Q38114903 | Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: a systematic review and meta-analysis |
| Q38056160 | The association between psoriasis and dyslipidaemia: a systematic review |
| Q38064779 | The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies |
| Q49625243 | The epidemiology of psoriatic arthritis in Israel - a population-based study |
| Q40132474 | Tofacitinib for the treatment of moderate to severe chronic plaque psoriasis in Japanese patients: Subgroup analyses from a randomized, placebo-controlled phase 3 trial. |
Search more.